Financial Performance - Revenue for H1 2025 reached CNY 399 million, with Q2 revenue of CNY 202 million, showing a year-on-year increase of 3.7% [2] - Net profit attributable to shareholders for H1 2025 was CNY 95.51 million, with a growth rate of 7.4% year-on-year [2] - Core product "PMC Ultra Bright" series saw a revenue increase of 32.4% year-on-year [2] Cost Management - Management expenses decreased by 11.4% year-on-year in Q2, with a management expense ratio of 9.2% [2] - Sales expenses decreased by 10.4% year-on-year in Q2, with a sales expense ratio of 16.7% [2] - R&D expenses increased by 35.5% year-on-year, indicating a strong focus on innovation [2][3] Product Development - New product matrix launched in H1 2025 includes high refractive index lenses (1.67, 1.71, 1.74) and smart photochromic lenses [4] - Sales of the "Easy Control" series reached CNY 81.67 million, a year-on-year increase of 7.32% [3] - The newly upgraded 1.74 series products saw a sales increase of 258% year-on-year [3] Strategic Partnerships - Xiaomi announced a partnership with Mingyue Lens for its AI glasses, enhancing the company's position in the smart wearable optics market [5] - A strategic cooperation agreement was signed with Aier Eye Hospital to deepen collaboration in the medical channel [5] Market Trends - The company maintains a strategic focus amidst increasing price competition in the industry, opting not to engage in price wars [10] - The market for defocus lenses is experiencing growth, with a near 20% increase in sales despite competitive pressures [10][12] Future Outlook - The company aims to enhance its brand, product, and service capabilities while focusing on long-term growth strategies [18] - Emphasis on maintaining a healthy industry ecosystem and avoiding price wars to ensure sustainable development [17]